EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

HDAC9‐mediated calmodulin deacetylation induces memory impairment in Alzheimer's disease

Hai-Long Zhang iD, Shufen Hu, Pin Yang, Han-Chun Long, Quan-Hong Ma, Dong-Min Yin, Guang-Yin Xu iD

CNS Neuroscience & Therapeutics · 2024

DOI: 10.1111/cns.14573 ↗

Kurz gefasst

Fachartikel in der Zeitschrift CNS Neuroscience & Therapeutics, 2024. Verfasst von Hai-Long Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Jiangsu Key Laboratory of Neuropsychiatric Diseases, Institute of Neuroscience, Suzhou Medical College of Soochow University, Medical Center of Sooch…. Hauptthemen laut MEDLINE: Alzheimer Disease, Neurodegenerative Diseases. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, China Postdoctoral Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Alzheimer's disease (AD) is a neurodegenerative disease characterized by progressive cognitive dysfunction and memory impairment. AD pathology involves protein acetylation. Previous studies have mainly focused on histone acetylation in AD, however, the roles of nonhistone acetylation in AD are less explored.

Methods

The protein acetylation and expression levels were detected by western blotting and co‐immunoprecipitation. The stoichiometry of acetylation was measured by home‐made and site‐specific antibodies against acetylated‐CaM (Ac‐CaM) at K22, K95, and K116. Hippocampus‐dependent learning and memory were evaluated by using the Morris water maze, novel object recognition, and contextual fear conditioning tests.

Results

We showed that calmodulin (CaM) acetylation is reduced in plasma of AD patients and mice. CaM acetylation and its target Ca 2+ /CaM‐dependent kinase II α (CaMKIIα) activity were severely impaired in AD mouse brain. The stoichiometry showed that Ac‐K22, K95‐CaM acetylation were decreased in AD patients and mice. Moreover, we screened and identified that lysine deacetylase 9 (HDAC9) was the main deacetylase for CaM. In addition, HDAC9 inhibition increased CaM acetylation and CaMKIIα activity, and hippocampus‐dependent memory in AD mice.

Conclusions

HDAC9‐mediated CaM deacetylation induces memory impairment in AD, HDAC9, or CaM acetylation may become potential therapeutic targets for AD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseNeurodegenerative DiseasesMiceHumansAnimalsCalmodulinMice, TransgenicMemory DisordersHippocampusDisease Models, AnimalHistone DeacetylasesRepressor Proteins

Stichwörter der Autor:innen

Alzheimer's diseaseCaMHDAC9acetylationmemory impairment

Substanzen

CalmodulinHDAC9 protein, humanHistone DeacetylasesRepressor Proteins

Autor:innen und Institutionen

  • Jiangsu Key Laboratory of Neuropsychiatric Diseases, Institute of Neuroscience, Suzhou Medical College of Soochow University, Medical Center of Soochow University, Suzhou, China.
  • Key Laboratory of Brain Functional Genomics, Ministry of Education and Shanghai, School of Life Science, East China Normal University, Shanghai, China.
  • Department of Neurology, The Affiliated Xingyi City Hospital of Guizhou Medical University, Xingyi, China.

ORCID-Profile: Hai-Long Zhang, Guang-Yin Xu

Förderung

  • National Natural Science Foundation of China
  • China Postdoctoral Science Foundation

Zitieren

APA

Zhang, H. L., Hu, S., Yang, P., Long, H. C., Ma, Q. H., Yin, D. M., & Xu, G. Y. (2024). HDAC9‐mediated calmodulin deacetylation induces memory impairment in Alzheimer's disease. CNS Neuroscience & Therapeutics. https://doi.org/10.1111/cns.14573

Vancouver

Zhang HL, Hu S, Yang P, Long HC, Ma QH, Yin DM, et al. HDAC9‐mediated calmodulin deacetylation induces memory impairment in Alzheimer's disease. CNS Neuroscience & Therapeutics. 2024. doi:10.1111/cns.14573

BibTeX
@article{Zhang2024,
  author = {Zhang, Hai-Long and Hu, Shufen and Yang, Pin and Long, Han-Chun and Ma, Quan-Hong and Yin, Dong-Min and Xu, Guang-Yin},
  title = {HDAC9‐mediated calmodulin deacetylation induces memory impairment in Alzheimer's disease},
  journal = {CNS Neuroscience & Therapeutics},
  year = {2024},
  doi = {10.1111/cns.14573}
}
Kostenlos starten →